Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells

被引：1
|
作者：
Xie, Leling [1 ,2 ]
Gu, Runxia [1 ,2 ]
Yang, Xue [1 ,2 ]
Qiu, Shaowei [1 ,2 ]
Xu, Yingxi [1 ,2 ]
Mou, Junli [1 ,2 ]
Wang, Ying [1 ,2 ]
Xing, Haiyan [1 ,2 ]
Tang, Kejing [1 ,2 ]
Tian, Zheng [1 ,2 ]
Rao, Qing [1 ,2 ]
Wang, Min [1 ,2 ]
Wang, Jianxiang [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4535 / 4535
页数：1
相关论文
共 50 条
  • [1] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    [J]. HUMAN GENE THERAPY, 2023, 34 (23-24) : 1257 - 1272
  • [2] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    [J]. BLOOD, 2021, 138
  • [3] Anti-CD7 CAR T cells for T-ALL: impressive early-stage efficacy
    David T. Teachey
    Stephen P. Hunger
    [J]. Nature Reviews Clinical Oncology, 2021, 18 : 677 - 678
  • [4] Anti-CD7 CAR T cells for T-ALL: impressive early-stage efficacy
    Teachey, David T.
    Hunger, Stephen P.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (11) : 677 - 678
  • [5] Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy
    Wang, Dongchu
    Wang, Hui
    [J]. BLOOD, 2023, 142
  • [6] HIGHLY EFFICIENT MULTIPLEXED BASE EDITING ENABLES DEVELOPMENT OF UNIVERSAL CD7-TARGETING CAR-T CELLS TO TREAT T-ALL
    Gehrke, Jason
    Edwards, Aaron
    Murray, Ryan
    Messana, Angelica
    Coholan, Lindsey
    Poulin, Henry
    Le, Melissa
    Ladd, Alden
    Naniong, Mark
    Musenge, Faith
    Camblin, Adam
    Poh, Yeh-Chuin
    Smith, Sarah
    Ciaramella, Giuseppe
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A69 - A69
  • [7] Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody
    Ye, Jing
    Jia, Yujie
    Tuhin, Israth Jahan
    Tan, Jingwen
    Monty, Masuma Akter
    Xu, Nan
    Kang, Liqing
    Li, Minghao
    Lou, Xiaoyan
    Zhou, Meixia
    Fang, Xiaoyan
    Shao, Jiaqi
    Zhu, Hongjia
    Yan, Zhiqiang
    Yu, Lei
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 719 - 728
  • [8] Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management
    Li, Shiqi
    Wang, Xinxin
    Yuan, Zhongtao
    Liu, Lin
    Luo, Le
    Li, Yu
    Wu, Kun
    Liu, Jia
    Yang, Chunhui
    Li, Zhimin
    Wang, Duanpeng
    Shen, Lianjun
    Ye, Xun
    He, Jiaping
    Han, Cong
    Wang, Youcheng
    Zhang, Dingsong
    Dong, Yancheng
    Fang, Lihua
    Chen, Yingnian
    Sersch, Martina
    Cao, Wei William
    Wang, Sanbin
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1242 - 1246
  • [9] Intracellular retention of TCRαβ/CD3 and CD7 to generate novel allogeneic CAR-T cells targeting CD7 for treating T-cell malignancies
    Li, Jun
    Liu, Kaichun
    Fu, Jianmin
    Chen, Shanshan
    Zhang, Yinhang
    Xu, Guanggui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies
    Zhang, Yinqiang
    Li, Chenggong
    Jiang, Huiwen
    Luo, Wenjing
    Du, Mengyi
    Zhou, Fen
    Tang, Lu
    Wu, Jianghua
    Wei, Qiuzhe
    Lu, Cong
    Kou, Haiming
    Wu, Di
    Alex, Chang H.
    Mei, Heng
    Hu, Yu
    [J]. BLOOD, 2022, 140 : 4592 - 4594
12345